Keyphrases
Chronic Kidney Disease
100%
Kidney
81%
Fibroblast Growth Factor 23 (FGF23)
73%
Kidney Transplant Recipients
31%
Kidney Transplantation
29%
Podocyte
27%
COVID-19
27%
Chronic Renal Insufficiency Cohort
26%
Angiotensin-converting Enzyme 2 (ACE2)
25%
Kidney Disease
25%
Transplantation
24%
Estimated Glomerular Filtration Rate
21%
Acute Kidney Injury
21%
End-stage Renal Disease
20%
Dialysis
20%
Confidence Interval
20%
Kidney Disease Progression
20%
Prox1
20%
Cardiovascular Disease
19%
Hypertension
19%
Kidney Transplant
17%
Angiotensin II (Ang II)
17%
United States
15%
Intact Parathyroid Hormone (iPTH)
15%
Proteinuria
15%
Lymphatic Vasculature
15%
Mouse Model
14%
Kidney Function
14%
Lymphatics
14%
Lymphatic Endothelial Cells
14%
Diabetes
14%
Diabetic Nephropathy
13%
Hemodialysis
13%
Inflammation
13%
Anemia
13%
Glomerulus
13%
T Cells
13%
Phosphate
13%
Cardiovascular Events
12%
Hazard Ratio
12%
Tacrolimus
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Pancreas
12%
Mineral Metabolism
12%
Diabetic Kidney Disease
11%
Transcription Factor
11%
Immunosuppression
11%
Six3
11%
High Risk
11%
Homeobox Genes
11%
Potassium
10%
Nephron
10%
Type 2 Diabetes Mellitus (T2DM)
10%
Risk Factors
10%
Vascular Endothelial Growth Factor
10%
Renin-angiotensin System
10%
Apolipoprotein L1 (APOL1)
9%
Placebo
9%
Transplantation Tolerance
9%
Renal Function
9%
Cardiovascular Risk
9%
Endothelial Cells
9%
Nephropathy
9%
Sirolimus
9%
Angiopoietin
9%
Bicarbonate
9%
Glomerular Disease
9%
Type I Diabetes
9%
Hemodialysis Patients
9%
Older Adults
9%
Nephrology
9%
Heart Failure
9%
Blood Pressure
9%
Clinical Outcomes
8%
Renal Disease
8%
Critically Ill Patients
8%
Glomerular Filtration Rate
8%
Acute Rejection
8%
Kidney Failure
8%
Serum Phosphate
8%
Steroidogenic Enzymes
8%
Mesangial Cells
8%
Liver Transplantation
8%
Evaluation Program
8%
Erythropoietin
8%
Transplant Recipients
8%
End-stage Kidney Disease
7%
Odds Ratio
7%
Treg
7%
Renal Transplant
7%
Randomized Controlled Trial
7%
Renal Transplant Recipients
7%
Insulin
7%
Nephrologists
7%
Mycophenolate Mofetil
7%
Knock-in Mouse Model
7%
Secondary Hyperparathyroidism
7%
Serum Phosphorus
7%
Kidney Development
7%
Diabetic Mice
7%
Medicine and Dentistry
Chronic Kidney Disease
97%
Kidney Graft
55%
Fibroblast Growth Factor 23
54%
Nephropathy
42%
Kidney Transplantation
37%
Lymph Duct
29%
Glomerular Filtration Rate
26%
Kidney Function
25%
End Stage Renal Disease
25%
Cohort Analysis
23%
Urinary System
22%
Cardiovascular System
21%
Diseases
21%
Biopsy Technique
20%
Biological Marker
20%
Cardiovascular Disease
20%
COVID-19
19%
Acute Kidney Injury
19%
Podocyte
18%
Diabetes
17%
Renal Failure
16%
Endothelial Cell
16%
Allograft
16%
Vascularity
16%
Diabetic Nephropathy
15%
Creatinine
15%
Hemodialysis
15%
Proteinuria
15%
Diabetes Mellitus
14%
Immunosuppressive Treatment
14%
Angiotensin Converting Enzyme 2
14%
Transplantation
13%
Acute Graft Rejection
13%
Parathyroid Hormone
13%
Infection
12%
Kidney Allograft
12%
Graft Survival
12%
Nephrology
11%
Nephron
11%
Glomerulopathy
11%
Infusion
11%
Anemia
11%
Living Donors
11%
Congestive Heart Failure
10%
T Cell
10%
Glomerulus
10%
Diseases
10%
Secretion (Process)
10%
Gene Expression
9%
Hazard Ratio
9%
Angiotensin II
9%
Organ Transplantation
9%
Epithelial Cell
9%
Transcription Factors
9%
Mineral Metabolism
9%
Blood Pressure
8%
Kidney Injury
8%
Isotopes of Calcium
8%
In Vitro
8%
Sodium Bicarbonate
8%
Prevalence
8%
Placebo
8%
Fibrosis
8%
Metabolic Acidosis
7%
Renal Biopsy
7%
Maturity Onset Diabetes of the Young
7%
Renin Angiotensin Aldosterone System
7%
Liver Transplantation
7%
Graft Rejection
7%
Insulin Dependent Diabetes Mellitus
7%
Nephrologist
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Homeobox
7%
Morphogenesis
7%
Renal Replacement Therapy
7%
Cell Proliferation
7%
Receptor
7%
Hyperkalemia
6%
Program Evaluation
6%
Mesangial Cell
6%
Vasculotropin
6%
Immunoglobulin A Nephropathy
6%
Acute Renal Failure
6%
Kidney Development
6%
Vitamin D
6%
Secondary Hyperparathyroidism
6%
Capillary
6%
Distal Renal Tubular Acidosis
6%
Randomized Controlled Trial
6%
Islet Transplantation
6%
B Cell
6%
Nephrotic Syndrome
6%
Apolipoprotein L1
6%
Clinical Trial
6%
Disease Exacerbation
5%
Immunosuppressive Drug
5%
Homeostasis
5%
Odds Ratio
5%
Progenitor Cell
5%
Quality of Life
5%